Testing for genetic risk factors could improve treatment for myeloma - a cancer of the blood and bone marrow - by helping doctors identify patients at risk of developing more aggressive disease.
Aug 17, 2015
0
41
As part of a multi-institutional effort, researchers with Huntsman Cancer Institute at the University of Utah have found that multiple myeloma patients with a genetic variation in the gene FOPNL die on average 1-3 years sooner ...
Jul 22, 2015
0
9
Genetic research is a key to understanding how either race or ethnicity affect the incidence of different cancers and how these factors may contribute to different responses to the same treatments. Multiple myeloma, a blood ...
Jul 15, 2015
0
20
Spending more leisure time sitting was associated with a higher risk of total cancer risk in women, and specifically with multiple myeloma, breast, and ovarian cancers, according a new study. The higher risk was present even ...
Jul 13, 2015
0
29
Multiple myeloma uses a trick akin to a wolf in sheep's clothing to grow in and spread to new bone sites. By overexpressing Runx2, a gene that normally is a master regulator of bone formation, the cells of this largely incurable ...
Jul 10, 2015
0
40
In a highly successful, first-of-its-kind endeavor, a multidisciplinary team of University of Wisconsin-Madison researchers have created a "tumor in a dish:" an ex vivo microenvironment that can accurately anticipate a multiple ...
Jun 12, 2015
0
24
(HealthDay)—A two-pronged immune-boosting drug could provide new hope for people stricken with multiple myeloma, a cancer of the blood and bone marrow, according to clinical trial findings.
Jun 2, 2015
0
20
Researchers have designed a nanoparticle-based therapy that is effective in treating mice with multiple myeloma, a cancer of immune cells in the bone marrow.
May 19, 2015
0
33
A new kind of immune therapy has shown promise against the third most common blood cancer, multiple myeloma, researchers said Wednesday.
May 13, 2015
0
6
Amgen Inc., the Thousand Oaks, Calif., biotech giant, said Sunday a new study has found its cancer drug Kyprolis is far more effective in treatment of relapsed multiple myeloma than its chief rival.
Mar 3, 2015
0
6
